Postdoctoral Fellow, Department of Radiology and Medicine, Stanford School of Medicine
Dr. Shukla received M.S. in Pharmacology & Toxicology from prestigious National Institute of Pharmaceutical Education & Research, India, and Ph.D. in Vascular Pharmacology and Electrophysiology from North Dakota State University, Fargo. His doctoral research work was aimed at elucidating the effects of melatonin on NO/cGMP/BKCasignaling in coronary arteries. He also worked on hTRPA1 and TRPV4 channel drug discovery program at Neuronal targets and Heart failure discovery performance unit, GlaxoSmithKline R&D, Philadelphia, USA. At present, Dr. Shukla is a cardiac & cellular electrophysiology postdoctoral fellow at Stanford University School of Medicine. In addition, he also serves as a member of the advisory board at Genetesis, LLC.
His area of research includes ion channel pharmacology, diseases modeling and drug screening using stem cell-derived cardiomyocytes and cardiac electrophysiology.In advisory capacity his role is to provide expertise in the design and execution of electrophysiological experiments aimed at delineating the specific ion channel signature underlying cardiac diseases.